A comprehensive view of Age 55+ / Seniors / Baby Boomers. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Chemicals Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck reports its next-generation pneumococcal shot V116 shows more effective immune response in older adults compared to its predecessor Pneumovax 23; V116 is effective against 83% of invasive pneumococcal diseases in older adults in the US

CDC advises adults aged 65 and older to get updated COVID-19 vaccine dosage for protection against JN.1 and other circulating variants, four months after previous dose

Sacroiliac joint fusion market forecast to grow at a CAGR of 18.6% by 2032 driven by aging population; population of US adults aged 65 and older expected to reach 95 million by 2060 according to CDC: DataHorizzon Research

GSK reports new long-term data show SHINGRIX vaccine continues to provide high protection against shingles in adults aged 50 and over for more than a decade

New York senate bill would automatically apply digital-only coupons offered through grocers’ loyalty programs to senior citizens; bill aims to address trend of loyalty cards and newspaper coupons being replaced by mobile apps, which seniors may not use

Ask us about our Chemicals Industry market view

Trending Chart

Interactive chart with headline count